Exact Mass: 474.193681
Exact Mass Matches: 474.193681
Found 500 metabolites which its exact mass value is equals to given mass value 474.193681
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sildenafil
C22H30N6O4S (474.20491400000003)
Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a form of ischaemic cardiovascular disease). Phase I clinical trials under the direction of Ian Osterloh suggested that the drug had little effect on angina, but that it could induce marked penile erections; Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and better erections. Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis) and vardenafil (Levitra); Sildenafil citrate, sold under the names Viagra, Revatio and generically under various other names, is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. Viagra pills are blue and diamond-shaped with the words Pfizer on one side, and VGR xx (where xx stands for 25, 50 or 100, the dose of that pill in milligrams) on the other. Its primary competitors on the market are tadalafil (Cialis), and vardenafil (Levitra). Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Quinapril hydrochloride
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is found in herbs and spices. 6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is a constituent of sage (Salvia officinalis) leaf. Constituent of sage (Salvia officinalis) leaf [DFC]. 6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is found in herbs and spices.
N-[2-(Diacetylamino)-3-(4-isothiocyanatophenyl)propyl]-N-[2-(diacetylamino)propyl]acetamide
2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid
C31H26N2O3 (474.19433260000005)
BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells[1][2][3].
Ibrutinib metabolite M37
C25H26N6O4 (474.20154360000004)
MeOSuc-AAPA-CMK
Mitopodozidum
N-(2-Benzyl-3-((2-amino-4-methylpentyl)dithio)-1-oxopropyl)glycine benzyl ester
5alpha,6beta,8alpha-Trihydroxy-28-norisotoonafolin
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-prop-2-enyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]oxane-3,4,5-triol
1-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]ethanone
[(4R,6aR,9S,9aR,9bR)-9-methyl-3,6-dimethylidene-2,8-dioxo-3a,4,5,6a,7,9,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] (E)-4-hydroxy-2-[[(E)-4-hydroxy-2-methylbut-2-enoyl]oxymethyl]but-2-enoate
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxy-4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol
(+)-(7S,8R,8R)-4,4,9-trihydroxy-3,5-dimethoxy-9-(5-hydroxy-4-oxo-pentanoyl)-2,7-cyclolignane|clemomanshurinane B
2-phenylpropionyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
4-(3-hydroxyprop-1-enyl)-2-methoxyphenyl 6-O-D-apio-beta-D-furanosyl-beta-D-glucopyranoside|coniferyl alcohol 4-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|ligusinenoside A
ligustrin-<4-hydroxy-5-(4,5-dihydroxytigloyloxy)-tiglate>|ligustrin-[4-hydroxy-5-(4,5-dihydroxytigloyloxy)-tiglate]
(+)-(7S,8R,8R)-4,4,9-trihydroxy-3,5-dimethoxy-9-(5-hydroxy-4-oxo-pentanoyl)-2,7-cyclolignane|clemomanshurinane A
NSC 72274; Podophyllic acid ethylhydrazide; Podophyllinic acid 2-ethylhydrazide
8beta-5-(4,5-dihydroxytigloyl)-4-hydroxytigloyloxydesacetylzuubergenin|8beta-5-<4,5-dihydroxytigloyl>-4-hydroxytigloyloxydesacetylzuubergenin
1-(4-beta-D-glucopyranosyloxybenzyl)-2-isobutyltartrate|coelovirin A
ligustrin-4-hydroxy-5-(2-1,2-dihydroxyacryloyl)-tiglate
Carvacrol 2-O-??-glucopyranosyl-(1鈥樏傗垎2)-??-glucopyranoside|carvacrol 20O-beta-glucopyranosyl-(1-2)-beta-glycopyranoside
2-(3,4-dihydroxy-4-hydroxymethyltetrahydrofuran-2-yl-oxymethyl)-6-[3-(4-hydroxy-3-methoxyphenyl)allyloxy]tetrahydropyran-3,4,5-triol|coniferyl 9-O-[beta-D-apiofuranosyl(1->6)]-O-beta-D-glucopyranoside
benzoic acid methyl ester 4-O-(3-O-methyl-alpha-L-rhamnopyranosyl)-(1->2)-beta-D-allopyranoside|keteleeroside C
10-beta-D-glucopyranosyloxy-3,9-dimethoxy-7-methoxymethyl-5H-dibenzo[a,c][7]annulene|subavenoside E
lobarin
A member of the class of 2-benzofurans that is 3-butyl-3-hydroxy-2-benzofuran-1(3H)-one substituted by a 3-carboxy-4,6-dihydroxy-2-pentylphenoxy group and a methoxy group at positions 4 and 6, respectively. It is a metabolite isolated from the Sumatran lichen, Stereocaulon halei.
3-methoxy-4-O-beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranosylpropiophenone
3-methoxy-4-O-beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranosylpropiophenone
1-O-isopropyl-[5-O-(4-hydroxybenzoyl)-beta-D-apiofuranosyl]-(1?2)-beta-D-glucopyranoside|clausenoside A
desacetoxyzuubergenin-8beta-4-hydroxy-5-(1,2-dihydroxyethylacryloyl)-tiglate
4-(4-beta-D-glucopyranosyloxybenzyl)-2-isobutyltartrate|coelovirin B
junipercomnoside E|trans-coniferyl alcohol 9-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside
3alpha,4alpha-epoxyligustrin-4-hydroxy-5-(4-hydroxytigloyl)-tiglate
6-O-beta-D-glucopyranosyl-2-O-(2-phenylpropionyl)-D-glucose
Coniferin 2-O-beta-D-apiofuranoside|coniferyl alcohol 4-O-beta-apiofuranosyl-(1->2)-beta-glucopyranoside|coniferylalcohol-4-O-2)>glucoside
4-hydroxy-2-isopropyl-5-methylphenyl O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside
(aS,5S,6S,7S)-5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-5-[Ac]oxybenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-ol|schisanwilsonin F
Asn Val Gln Asp
C18H30N6O9 (474.20741699999996)
C21H30O12_beta-D-Glucopyranoside, 2-hydroxy-4-(2-propen-1-yl)phenyl 6-O-beta-D-glucopyranosyl
C21H30O12_4-Allyl-2-(beta-D-glucopyranosyloxy)phenyl beta-D-glucopyranoside
C25H30O9_(4R,6aR,9S,9aR,9bR)-9-Methyl-3,6-bis(methylene)-2,8-dioxododecahydroazuleno[4,5-b]furan-4-yl (2E)-4-hydroxy-2-({[(2E)-4-hydroxy-2-methyl-2-butenoyl]oxy}methyl)-2-butenoate
C21H30O12_4-Acetyl-2-methoxyphenyl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
sildenafil
C22H30N6O4S (474.20491400000003)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxy-4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol_major
1-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]ethanone_major
Ala Glu Gln Gln
C18H30N6O9 (474.20741699999996)
Ala Gln Glu Gln
C18H30N6O9 (474.20741699999996)
Ala Gln Gln Glu
C18H30N6O9 (474.20741699999996)
Cys Cys His Ile
Cys Cys His Leu
Cys Cys Ile His
Cys Cys Leu His
Cys His Cys Ile
Cys His Cys Leu
Cys His Ile Cys
Cys His Leu Cys
Cys Ile Cys His
Cys Ile His Cys
Cys Leu Cys His
Cys Leu His Cys
Cys Pro Gln Gln
Cys Gln Pro Gln
Cys Gln Gln Pro
Asp Phe Gly His
Asp Phe His Gly
Asp Phe Pro Pro
Asp Gly Phe His
Asp Gly His Phe
Asp His Phe Gly
Asp His Gly Phe
Asp Ile Met Pro
C20H34N4O7S (474.21480940000004)
Asp Ile Asn Asn
C18H30N6O9 (474.20741699999996)
Asp Ile Pro Met
C20H34N4O7S (474.21480940000004)
Asp Leu Met Pro
C20H34N4O7S (474.21480940000004)
Asp Leu Asn Asn
C18H30N6O9 (474.20741699999996)
Asp Leu Pro Met
C20H34N4O7S (474.21480940000004)
Asp Met Ile Pro
C20H34N4O7S (474.21480940000004)
Asp Met Leu Pro
C20H34N4O7S (474.21480940000004)
Asp Met Pro Ile
C20H34N4O7S (474.21480940000004)
Asp Met Pro Leu
C20H34N4O7S (474.21480940000004)
Asp Asn Ile Asn
C18H30N6O9 (474.20741699999996)
Asp Asn Leu Asn
C18H30N6O9 (474.20741699999996)
Asp Asn Asn Ile
C18H30N6O9 (474.20741699999996)
Asp Asn Asn Leu
C18H30N6O9 (474.20741699999996)
Asp Asn Gln Val
C18H30N6O9 (474.20741699999996)
Asp Asn Val Gln
C18H30N6O9 (474.20741699999996)
Asp Pro Phe Pro
Asp Pro Ile Met
C20H34N4O7S (474.21480940000004)
Asp Pro Leu Met
C20H34N4O7S (474.21480940000004)
Asp Pro Met Ile
C20H34N4O7S (474.21480940000004)
Asp Pro Met Leu
C20H34N4O7S (474.21480940000004)
Asp Pro Pro Phe
Asp Gln Asn Val
C18H30N6O9 (474.20741699999996)
Asp Gln Val Asn
C18H30N6O9 (474.20741699999996)
Asp Val Asn Gln
C18H30N6O9 (474.20741699999996)
Asp Val Gln Asn
C18H30N6O9 (474.20741699999996)
Glu Ala Gln Gln
C18H30N6O9 (474.20741699999996)
Glu Glu Pro Thr
Glu Glu Thr Pro
Glu Met Pro Val
C20H34N4O7S (474.21480940000004)
Glu Met Val Pro
C20H34N4O7S (474.21480940000004)
Glu Asn Asn Val
C18H30N6O9 (474.20741699999996)
Glu Asn Val Asn
C18H30N6O9 (474.20741699999996)
Glu Pro Glu Thr
Glu Pro Met Val
C20H34N4O7S (474.21480940000004)
Glu Pro Thr Glu
Glu Pro Val Met
C20H34N4O7S (474.21480940000004)
Glu Gln Ala Gln
C18H30N6O9 (474.20741699999996)
Glu Gln Gln Ala
C18H30N6O9 (474.20741699999996)
Glu Arg Asn Gly
C17H30N8O8 (474.21864999999997)
Glu Thr Glu Pro
Glu Thr Pro Glu
Glu Val Met Pro
C20H34N4O7S (474.21480940000004)
Glu Val Asn Asn
C18H30N6O9 (474.20741699999996)
Glu Val Pro Met
C20H34N4O7S (474.21480940000004)
Phe Asp Gly His
Phe Asp His Gly
Phe Asp Pro Pro
Phe Gly Asp His
Phe Gly His Asp
Phe His Asp Gly
Phe His Gly Asp
Phe Pro Asp Pro
Phe Pro Pro Asp
Gly Asp Phe His
Gly Asp His Phe
Gly Asp Gln Arg
C17H30N8O8 (474.21864999999997)
Gly Asp Arg Gln
C17H30N8O8 (474.21864999999997)
Gly Glu Asn Arg
C17H30N8O8 (474.21864999999997)
Gly Phe Asp His
Gly Phe His Asp
Gly His Asp Phe
Gly His Phe Asp
Gly His Met Met
Gly Met His Met
Gly Met Met His
His Cys Cys Ile
His Cys Cys Leu
His Cys Ile Cys
His Cys Leu Cys
His Asp Phe Gly
His Asp Gly Phe
His Phe Asp Gly
His Phe Gly Asp
His Gly Asp Phe
His Gly Phe Asp
His Gly Met Met
His Ile Cys Cys
His Leu Cys Cys
His Met Gly Met
His Met Met Gly
His Met Ser Thr
His Met Thr Ser
His Ser Met Thr
His Ser Thr Met
His Thr Met Ser
His Thr Ser Met
Ile Cys Cys His
Ile Cys His Cys
Ile Asp Met Pro
C20H34N4O7S (474.21480940000004)
Ile Asp Asn Asn
C18H30N6O9 (474.20741699999996)
Ile Asp Pro Met
C20H34N4O7S (474.21480940000004)
Ile His Cys Cys
Ile Met Asp Pro
C20H34N4O7S (474.21480940000004)
Ile Met Pro Asp
C20H34N4O7S (474.21480940000004)
Ile Asn Asp Asn
C18H30N6O9 (474.20741699999996)
Ile Asn Asn Asp
C18H30N6O9 (474.20741699999996)
Ile Pro Asp Met
C20H34N4O7S (474.21480940000004)
Ile Pro Met Asp
C20H34N4O7S (474.21480940000004)
Leu Cys Cys His
Leu Cys His Cys
Leu Asp Met Pro
C20H34N4O7S (474.21480940000004)
Leu Asp Asn Asn
C18H30N6O9 (474.20741699999996)
Leu Asp Pro Met
C20H34N4O7S (474.21480940000004)
Leu His Cys Cys
Leu Met Asp Pro
C20H34N4O7S (474.21480940000004)
Leu Met Pro Asp
C20H34N4O7S (474.21480940000004)
Leu Asn Asp Asn
C18H30N6O9 (474.20741699999996)
Leu Asn Asn Asp
C18H30N6O9 (474.20741699999996)
Leu Pro Asp Met
C20H34N4O7S (474.21480940000004)
Leu Pro Met Asp
C20H34N4O7S (474.21480940000004)
Met Asp Ile Pro
C20H34N4O7S (474.21480940000004)
Met Asp Leu Pro
C20H34N4O7S (474.21480940000004)
Met Asp Pro Ile
C20H34N4O7S (474.21480940000004)
Met Asp Pro Leu
C20H34N4O7S (474.21480940000004)
Met Glu Pro Val
C20H34N4O7S (474.21480940000004)
Met Glu Val Pro
C20H34N4O7S (474.21480940000004)
Met Gly His Met
Met Gly Met His
Met His Gly Met
Met His Met Gly
Met His Ser Thr
Met His Thr Ser
Met Ile Asp Pro
C20H34N4O7S (474.21480940000004)
Met Ile Pro Asp
C20H34N4O7S (474.21480940000004)
Met Leu Asp Pro
C20H34N4O7S (474.21480940000004)
Met Leu Pro Asp
C20H34N4O7S (474.21480940000004)
Met Met Gly His
Met Met His Gly
Met Met Pro Pro
Met Asn Asn Pro
Met Asn Pro Asn
Met Pro Asp Ile
C20H34N4O7S (474.21480940000004)
Met Pro Asp Leu
C20H34N4O7S (474.21480940000004)
Met Pro Glu Val
C20H34N4O7S (474.21480940000004)
Met Pro Ile Asp
C20H34N4O7S (474.21480940000004)
Met Pro Leu Asp
C20H34N4O7S (474.21480940000004)
Met Pro Met Pro
Met Pro Asn Asn
Met Pro Pro Met
Met Pro Val Glu
C20H34N4O7S (474.21480940000004)
Met Ser His Thr
Met Ser Thr His
Met Thr His Ser
Met Thr Ser His
Met Val Glu Pro
C20H34N4O7S (474.21480940000004)
Met Val Pro Glu
C20H34N4O7S (474.21480940000004)
Asn Asp Ala Arg
C17H30N8O8 (474.21864999999997)
Asn Asp Ile Asn
C18H30N6O9 (474.20741699999996)
Asn Asp Leu Asn
C18H30N6O9 (474.20741699999996)
Asn Asp Asn Ile
C18H30N6O9 (474.20741699999996)
Asn Asp Asn Leu
C18H30N6O9 (474.20741699999996)
Asn Asp Gln Val
C18H30N6O9 (474.20741699999996)
Asn Asp Val Gln
C18H30N6O9 (474.20741699999996)
Asn Glu Asn Val
C18H30N6O9 (474.20741699999996)
Asn Glu Val Asn
C18H30N6O9 (474.20741699999996)
Asn Gly Glu Arg
C17H30N8O8 (474.21864999999997)
Asn Gly Arg Glu
C17H30N8O8 (474.21864999999997)
Asn Ile Asp Asn
C18H30N6O9 (474.20741699999996)
Asn Ile Asn Asp
C18H30N6O9 (474.20741699999996)
Asn Leu Asp Asn
C18H30N6O9 (474.20741699999996)
Asn Leu Asn Asp
C18H30N6O9 (474.20741699999996)
Asn Met Asn Pro
Asn Met Pro Asn
Asn Asn Asp Ile
C18H30N6O9 (474.20741699999996)
Asn Asn Asp Leu
C18H30N6O9 (474.20741699999996)
Asn Asn Glu Val
C18H30N6O9 (474.20741699999996)
Asn Asn Ile Asp
C18H30N6O9 (474.20741699999996)
Asn Asn Leu Asp
C18H30N6O9 (474.20741699999996)
Asn Asn Met Pro
Asn Asn Asn Asn
C16H26N8O9 (474.18226660000005)
Asn Asn Pro Met
Asn Asn Val Glu
C18H30N6O9 (474.20741699999996)
Asn Pro Met Asn
Asn Pro Asn Met
Asn Gln Asp Val
C18H30N6O9 (474.20741699999996)
Asn Gln Val Asp
C18H30N6O9 (474.20741699999996)
Asn Arg Ala Asp
C17H30N8O8 (474.21864999999997)
Asn Arg Asp Ala
C17H30N8O8 (474.21864999999997)
Asn Arg Glu Gly
C17H30N8O8 (474.21864999999997)
Asn Arg Gly Glu
C17H30N8O8 (474.21864999999997)
Asn Val Asp Gln
C18H30N6O9 (474.20741699999996)
Asn Val Glu Asn
C18H30N6O9 (474.20741699999996)
Asn Val Asn Glu
C18H30N6O9 (474.20741699999996)
Pro Cys Gln Gln
Pro Asp Phe Pro
Pro Asp Ile Met
C20H34N4O7S (474.21480940000004)
Pro Asp Leu Met
C20H34N4O7S (474.21480940000004)
Pro Asp Met Ile
C20H34N4O7S (474.21480940000004)
Pro Asp Met Leu
C20H34N4O7S (474.21480940000004)
Pro Asp Pro Phe
Pro Glu Glu Thr
Pro Glu Met Val
C20H34N4O7S (474.21480940000004)
Pro Glu Thr Glu
Pro Glu Val Met
C20H34N4O7S (474.21480940000004)
Pro Phe Asp Pro
Pro Phe Pro Asp
Pro Ile Asp Met
C20H34N4O7S (474.21480940000004)
Pro Ile Met Asp
C20H34N4O7S (474.21480940000004)
Pro Leu Asp Met
C20H34N4O7S (474.21480940000004)
Pro Leu Met Asp
C20H34N4O7S (474.21480940000004)
Pro Met Asp Ile
C20H34N4O7S (474.21480940000004)
Pro Met Asp Leu
C20H34N4O7S (474.21480940000004)
Pro Met Glu Val
C20H34N4O7S (474.21480940000004)
Pro Met Ile Asp
C20H34N4O7S (474.21480940000004)
Pro Met Leu Asp
C20H34N4O7S (474.21480940000004)
Pro Met Met Pro
Pro Met Asn Asn
Pro Met Pro Met
Pro Met Val Glu
C20H34N4O7S (474.21480940000004)
Pro Asn Met Asn
Pro Asn Asn Met
Pro Pro Asp Phe
Pro Pro Phe Asp
Pro Pro Met Met
Pro Gln Cys Gln
Pro Gln Gln Cys
Pro Thr Glu Glu
Pro Val Glu Met
C20H34N4O7S (474.21480940000004)
Pro Val Met Glu
C20H34N4O7S (474.21480940000004)
Gln Ala Glu Gln
C18H30N6O9 (474.20741699999996)
Gln Ala Gln Glu
C18H30N6O9 (474.20741699999996)
Gln Cys Pro Gln
Gln Cys Gln Pro
Gln Asp Gly Arg
C17H30N8O8 (474.21864999999997)
Gln Asp Asn Val
C18H30N6O9 (474.20741699999996)
Gln Asp Arg Gly
C17H30N8O8 (474.21864999999997)
Gln Asp Val Asn
C18H30N6O9 (474.20741699999996)
Gln Glu Ala Gln
C18H30N6O9 (474.20741699999996)
Gln Glu Gln Ala
C18H30N6O9 (474.20741699999996)
Gln Gly Asp Arg
C17H30N8O8 (474.21864999999997)
Gln Gly Arg Asp
C17H30N8O8 (474.21864999999997)
Gln Asn Asp Val
C18H30N6O9 (474.20741699999996)
Gln Asn Val Asp
C18H30N6O9 (474.20741699999996)
Gln Pro Cys Gln
Gln Pro Gln Cys
Gln Gln Ala Glu
C18H30N6O9 (474.20741699999996)
Gln Gln Cys Pro
Gln Gln Glu Ala
C18H30N6O9 (474.20741699999996)
Gln Gln Pro Cys
Gln Arg Asp Gly
C17H30N8O8 (474.21864999999997)
Gln Arg Gly Asp
C17H30N8O8 (474.21864999999997)
Gln Val Asp Asn
C18H30N6O9 (474.20741699999996)
Gln Val Asn Asp
C18H30N6O9 (474.20741699999996)
Arg Ala Asp Asn
C17H30N8O8 (474.21864999999997)
Arg Ala Asn Asp
C17H30N8O8 (474.21864999999997)
Arg Asp Ala Asn
C17H30N8O8 (474.21864999999997)
Arg Asp Gly Gln
C17H30N8O8 (474.21864999999997)
Arg Asp Asn Ala
C17H30N8O8 (474.21864999999997)
Arg Glu Gly Asn
C17H30N8O8 (474.21864999999997)
Ser His Met Thr
Ser His Thr Met
Ser Met His Thr
Ser Met Thr His
Ser Thr His Met
Ser Thr Met His
Thr Glu Glu Pro
Thr Glu Pro Glu
Thr His Met Ser
Thr His Ser Met
Thr Met His Ser
Thr Met Ser His
Thr Pro Glu Glu
Thr Ser His Met
Thr Ser Met His
Val Asp Asn Gln
C18H30N6O9 (474.20741699999996)
Val Asp Gln Asn
C18H30N6O9 (474.20741699999996)
Val Glu Met Pro
C20H34N4O7S (474.21480940000004)
Val Glu Asn Asn
C18H30N6O9 (474.20741699999996)
Val Glu Pro Met
C20H34N4O7S (474.21480940000004)
Val Met Glu Pro
C20H34N4O7S (474.21480940000004)
Val Met Pro Glu
C20H34N4O7S (474.21480940000004)
Val Asn Asp Gln
C18H30N6O9 (474.20741699999996)
Val Asn Glu Asn
C18H30N6O9 (474.20741699999996)
Val Asn Asn Glu
C18H30N6O9 (474.20741699999996)
Val Asn Gln Asp
C18H30N6O9 (474.20741699999996)
Val Pro Glu Met
C20H34N4O7S (474.21480940000004)
Val Pro Met Glu
C20H34N4O7S (474.21480940000004)
Val Gln Asp Asn
C18H30N6O9 (474.20741699999996)
Val Gln Asn Asp
C18H30N6O9 (474.20741699999996)
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside
4-Acetyl-2-methoxyphenyl 6-O-(6-deoxy-?-L-mannopyranosyl)-?-D-glucopyranoside
(4R,6aR,9S,9aR,9bR)-9-Methyl-3,6-bis(methylene)-2,8-dioxododecahydroazuleno[4,5-b]furan-4-yl (2E)-4-hydroxy-2-({[(2E)-4-hydroxy-2-methyl-2-butenoyl]oxy}methyl)-2-butenoate
ETHYL 4-(2,4-BIS(BENZYLOXY)-5-ISOPROPYLPHENYL)-2-HYDROXY-4-OXOBUT-2-ENOATE
butyl prop-2-enoate,2-methylprop-2-enoic acid,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,prop-2-enenitrile
C21H34N2O8S (474.20357640000003)
N-[2-(4-{[4-(Cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino}-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-trien-11-yl)-2-oxoethyl]acetamide
C23H25F3N6O2 (474.19909859999996)
[9,10-Di(1-naphthyl)-2-anthryl]boronic acid
C34H23BO2 (474.17910079999996)
TRIMETHYL((4-((4-((4-(PHENYLETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)SILANE
(R)-4-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-(((BENZYLOXY)CARBONYL)AMINO)BUTANOIC ACID
MITOPODOZIDE
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C1331 - Epipodophyllotoxin Compound C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents C1907 - Drug, Natural Product
pf-03814735
C23H25F3N6O2 (474.19909859999996)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2-benzofuran-1,3-dione,2,2-dimethylpropane-1,3-diol,hexanedioic acid,propane-1,3-diol
ZD 7155 hydrochloride
ZD 7155 hydrochloride is an angiotensin II receptor type 1 (AT1 receptor) antagonist.
methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazole-[3,4-c]pyridine-3-carboxylate
C26H26N4O5 (474.19031060000003)
[9,10-Di(2-naphthyl)-2-anthryl]boronic acid
C34H23BO2 (474.17910079999996)
benzene-1,3-dicarboxylic acid,furan-2,5-dione,3-(3-hydroxypropoxy)propan-1-ol,propane-1,2-diol
Fosmetpantotenate
C20H31N2O9P (474.17670860000004)
C307 - Biological Agent > C29726 - Enzyme Replacement or Supplement Agent
[(3R,4R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl] 4-(2-hydroxybenzoyl)benzoate
Keoxifene
C28H28NO4S+ (474.1738948000001)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D050071 - Bone Density Conservation Agents
Ananolignan D
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.
Ananolignan E
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.
MSACK
D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones
(1-methylsulfonylpiperidin-4-yl) N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate
C20H34N4O7S (474.21480940000004)
6-Amino-4-(3-{[4-(4-fluorophenyl)piperazin-1-yl]methyl}-4-methoxyphenyl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
(3aS,4R,9bR)-N-(2,5-difluorophenyl)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(1S,9R,10R,11R)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C26H26N4O5 (474.19031060000003)
1-(4-chlorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(3-chlorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(2R,3S,6S)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
1-(2-chlorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
2-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
(1R,9S,10S,11S)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C26H26N4O5 (474.19031060000003)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-6-oxo-N-phenyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H26N4O5 (474.19031060000003)
methyl (1R,9S,10S,11S)-12-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(4-chlorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
2-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-6-oxo-N-phenyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H26N4O5 (474.19031060000003)
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(2-chlorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
2-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-(2,3-dihydro-1H-inden-2-yl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(3-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
(1R,5S)-N-(3-chlorophenyl)-7-[4-[3-[dimethylamino(oxo)methyl]phenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
[(4R,6aR,9S,9aR,9bR)-9-methyl-3,6-dimethylidene-2,8-dioxo-3a,4,5,6a,7,9,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] (Z)-4-hydroxy-2-[[(E)-4-hydroxy-2-methylbut-2-enoyl]oxymethyl]but-2-enoate
N-[4-[[4-(3-cyanobenzoyl)piperazin-1-yl]methyl]phenyl]-4-methylbenzenesulfonamide
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] nonanoate
C18H35O12P (474.18660400000005)
SB-277011 (hydrochloride)
SB-277011 hydrochloride (SB-277011A hydrochloride) is a potent, selective, orally bioavailable and brain penetrate?dopamine D3?receptor (D3R)?antagonist with Ki values of 10.7?nM and?11.2 nM?at?rodent and human?D3R, respectively. SB-277011 hydrochloride displays 80- to 100-fold selectivity over other dopamine receptors with?pKis of 8.0, 6.0, <5.2, and 5.9 for D3, D2, 5-HT1B, and 5-HT1D receptors, respectively[1][2].